Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000293663 refers to a predicted or computationally annotated gene product described as "novel protein similar to embryonic testis differentiation homolog A." There is no characterized function, validated molecular family, or established disease link for this protein. Such annotations are often the output of genome projects predicting open reading frames with low or no experimental validation. As a result, it does not constitute a validated therapeutic target, and no standard abbreviation, aliases, or detailed insights are available. If you are seeking information on a validated target used in translational research or drug development, a different, well-established gene/protein entry (with a standardized name and clear biological context) would be necessary.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel protein similar to embryonic testis differentiation homolog A.